scholarly journals Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units.

1988 ◽  
Vol 41 (2) ◽  
pp. 138-142 ◽  
Author(s):  
J T Wilde ◽  
K M Roberts ◽  
M Greaves ◽  
F E Preston
2015 ◽  
Vol 39 (6) ◽  
Author(s):  
Ali Kemal Erenler ◽  
Turker Yardan

AbstractPresepsin is a 13-kDa protein that is a fragment of CD14 with truncated N-terminal, the receptor for lipopolysaccharide (LPS)/LPS-binding protein complexes. It is a novel marker being sought in many diseases such as sepsis, kidney failure, disseminated intravascular coagulation, etc. In this review, we aimed to clarify its utility in critical diseases and availability in critical care settings such as emergency departments and intensive care units.


2018 ◽  
Vol 41 (1) ◽  
pp. 32-38
Author(s):  
Wiralpat Padungmaneesub ◽  
Sanit Reungrongrat ◽  
Suphara Manowong ◽  
Kanda Fanhchaksai ◽  
Noppamas Panyasit ◽  
...  

1989 ◽  
Vol 17 (1) ◽  
pp. 49-55 ◽  
Author(s):  
J. G. Brock-Utne ◽  
S. L. Gaffin

Endotoxins (lipopolysaccharides, LPS) are potent bacterial poisons always present within the intestines in considerable amounts. Several pathophysiological conditions such as hypovolaemia, hypoxia, intestinal ischaemia, burns and radiation lead to a breakdown in the barrier and depending upon the extent of the injury, endotoxins enter the systemic circulation in increasing amounts. Antibiotics do not inactivate the endotoxins which continue to exert their toxic effects leading to nausea, vomiting, diarrhoea, fever, disseminated intravascular coagulation, vascular collapse and organ failure. When nonabsorbable antibiotics are given prior to the insult, systemic endotoxaemia is prevented. Immunotherapy, using anti-lipopolysaccharide IgG, inactivates plasma endotoxins, destroys gram-negative bacteria and opsonises them and may become a major form of therapy. An outline of endotoxin and anti-lipopolysaccharide and its importance to the anaesthetist and intensive care specialist is presented.


Author(s):  
S. O. Tarasenko ◽  
S. O. Dubrov ◽  
G. G. Suslov

The clinical manifestations of disseminated intravascular coagulation syndrome (DIC) depend on the predominance of the sum of the vectors of hypercoagulation and hyperfibrinolysis and are strongly associated with the underlying disease, against which DIC is formed. The issue of understanding the complex pathogenesis, timely diagnosis of overt DIC and early manifestations of DIC remain an urgent challenge for intensive care physicians and leading specialized societies to study the problems of hemostasis and thrombus formation. This review of the literature analyzes the pathways of DIC development, the current state of the possibility of using diagnostic markers to detect DIC, especially in sepsis. The diagnosis of sepsis-induced coagulopathy against the background of the development of multiple organ failure is highlighted as a separate issue. Diagnostic scales are presented in the form of comparative tables for a more convenient perception of information, memorization and further implementation in clinical practice.


Sign in / Sign up

Export Citation Format

Share Document